Chronic Lymphocytic Leukemia
| TREATMENT REGIMENS | |||||
|---|---|---|---|---|---|
| Patient < 70 years old without significant comorbidities | |||||
| R-FC | |||||
| Patient > 70 years old or with significant comorbidities | |||||
| Venetoclax + obinutuzumab | |||||
| Venetoclax | |||||
| Acalabrutinib + obinutuzumab | |||||
| Ibrutinib | |||||
| Bendamustine | |||||
| Chlorambucil + obinutuzumab | |||||
| Idelalisib + rituximab | |||||
| CVP (COP) | |||||
| Chlorambucil | |||||
| Fludarabine-R | |||||
| Fludarabine IV / PO | |||||
Groupe d'étude en oncologie du Québec